BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 14702631)

  • 21. Downregulation of IL-12 and a novel negative feedback system mediated by CD25+CD4+ T cells.
    Sato K; Tateishi S; Kubo K; Mimura T; Yamamoto K; Kanda H
    Biochem Biophys Res Commun; 2005 Apr; 330(1):226-32. PubMed ID: 15781254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cells can initiate protective immune responses against malaria.
    Bruña-Romero O; Rodriguez A
    Infect Immun; 2001 Aug; 69(8):5173-6. PubMed ID: 11447201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effector and memory CD8+ T cells as seen in immunity to malaria.
    Morrot A; Zavala F
    Immunol Rev; 2004 Oct; 201():291-303. PubMed ID: 15361248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmodium berghei XAT: contribution of gammadelta T cells to host defense against infection with blood-stage nonlethal malaria parasite.
    Kobayashi F; Niikura M; Waki S; Matsui T; Fujino T; Tsuruhara T; Kamiya S
    Exp Parasitol; 2007 Dec; 117(4):368-75. PubMed ID: 17601562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
    Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative.
    Ghiringhelli F; Larmonier N; Schmitt E; Parcellier A; Cathelin D; Garrido C; Chauffert B; Solary E; Bonnotte B; Martin F
    Eur J Immunol; 2004 Feb; 34(2):336-44. PubMed ID: 14768038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmodium yoelii: resistance to disease is linked to the mtv-7 locus in BALB/c mice.
    Swardson CJ; Wassom DL; Avery AC
    Exp Parasitol; 1997 Jun; 86(2):102-9. PubMed ID: 9207740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice.
    Sharma SK; Farah D; Misra-Bhattacharya S; Bajpai P; Agarwal A; Mohammad O
    Vaccine; 2006 Feb; 24(7):948-56. PubMed ID: 16168527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell-mediated immunity in malaria. I. The Ly phenotype of T cells mediating resistance to Plasmodium yoelii.
    Jayawardena AN; Murphy DB; Janeway CA; Gershon RK
    J Immunol; 1982 Jul; 129(1):377-81. PubMed ID: 6979570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of CD4+CD25+ regulatory T cells in viral infections.
    Vahlenkamp TW; Tompkins MB; Tompkins WA
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):219-25. PubMed ID: 16126280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo.
    Delgado M; Chorny A; Gonzalez-Rey E; Ganea D
    J Leukoc Biol; 2005 Dec; 78(6):1327-38. PubMed ID: 16204628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+CD25+ regulatory T cells and graft-versus-host disease.
    Hoffmann P; Edinger M
    Semin Hematol; 2006 Jan; 43(1):62-9. PubMed ID: 16412790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural regulatory T cells in infectious disease.
    Belkaid Y; Rouse BT
    Nat Immunol; 2005 Apr; 6(4):353-60. PubMed ID: 15785761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
    Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
    Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of early cellular immune factors regulating growth of malaria parasites in humans.
    Good MF
    Immunity; 2005 Sep; 23(3):241-2. PubMed ID: 16169495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uninfected mosquito bites confer protection against infection with malaria parasites.
    Donovan MJ; Messmore AS; Scrafford DA; Sacks DL; Kamhawi S; McDowell MA
    Infect Immun; 2007 May; 75(5):2523-30. PubMed ID: 17339356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.
    Nishikawa H; Kato T; Tawara I; Takemitsu T; Saito K; Wang L; Ikarashi Y; Wakasugi H; Nakayama T; Taniguchi M; Kuribayashi K; Old LJ; Shiku H
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9253-7. PubMed ID: 15961541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient development of plasmodium liver stage-specific memory CD8+ T cells during the course of blood-stage malarial infection.
    Hafalla JC; Rai U; Bernal-Rubio D; Rodriguez A; Zavala F
    J Infect Dis; 2007 Dec; 196(12):1827-35. PubMed ID: 18190264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.